Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 1.00 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | FLT3 | P36888 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | DAO | P14920 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.47 |
| ▸ | DDO | Q99489 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29363162 | 1.00 | AOC3 (1.00) | AOC3LOXL2NPC1RAB9ACA2 | |
| Hydrochloric Acid SCHEMBL28968677 | 0.98 | AOC3 (1.00) | AOC3LOXL2NPC1RAB9ACA2 | |
| Hydrochloric Acid SCHEMBL5435898 | 0.98 | AOC3 (1.00) | AOC3LOXL2NPC1RAB9ACA2 | |
| Iodide SCHEMBL2316310 | 0.98 | AOC3 (0.95) | AOC3LOXL2NPC1RAB9ACA2 | |
| SCHEMBL28494735 | 0.89 | AOC3 (0.80) | AOC3LOXL2NPC1RAB9ACA2 | |
| Urea SCHEMBL28162531 | 0.89 | AOC3 (0.80) | AOC3LOXL2NPC1RAB9ACA2 | |
| Pyrrole SCHEMBL412879 | 0.89 | AOC3 (0.80) | AOC3LOXL2NPC1RAB9ACA2 | |
| Pyrrole SCHEMBL27718192 | 0.89 | AOC3 (0.80) | AOC3LOXL2NPC1RAB9ACA2 | |
| SCHEMBL28124326 | 0.88 | AOC3 (0.77) | AOC3LOXL2NPC1RAB9ACA2 | |
| SCHEMBL27747908 | 0.84 | AOC3 (0.71) | AOC3LOXL2NPC1RAB9ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10759 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122095084-A | Antigen-specific T cell receptors and chimeric antigen receptors and methods of use in modulation of immune signaling for cancer immunotherapy | — | 2026-05-26 | — | — | CN | claimed |
| US-20260137817-A1 | COMBINATION CANCER IMMUNOTHERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX | GALERA LABS LLC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4602064-B1 | METHOD OF MANUFACTURING A PEPTIDE WITH A LYSINE DERIVATIVE | BACHEM HOLDING AG (CH) | 2026-05-13 | — | — | EP | claimed |
| EP-4731758-A2 | ANTIGEN-SPECIFIC T CELL RECEPTORS AND CHIMERIC ANTIGEN RECEPTORS, AND METHODS OF USE IN IMMUNE SIGNALING MODULATION FOR CANCER IMMUNOTHERAPY | The Methodist Hospital (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4688823-A2 | BIFUNCTIONAL MOLECULES TARGETING LYMPH NODE PROGENITOR EXHAUSTED T CELLS AND METHODS OF USE | The Board of Trustees of the Leland Stanford Junior University (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4076482-B1 | COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, ENHANCING DRUG POTENCY AND TREATING CANCER | PERSEPHONE BIOSCIENCES INC (US) | 2025-11-26 | — | — | EP | claimed |
| US-20250304573-A1 | LYSERGIC ACID DERIVATIVES AND METHODS | UNIV FLORIDA STATE RES FOUND INC (US) | 2025-10-02 | — | — | US | claimed |
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| US-12415988-B2 | Enhanced differentiation of mesenchymal stem cells | ESCAPE THERAPEUTICS, INC. | 2025-09-16 | — | — | US | claimed |
| EP-4602064-A1 | METHOD OF MANUFACTURING A PEPTIDE WITH A LYSINE DERIVATIVE | Bachem Holding AG (CH) | 2025-08-20 | — | — | EP | claimed |
| EP-0131007-A1 | GnRH AGONISTS. | SALK INST FOR BIOLOGICAL STUDI (US) | 1985-01-16 | — | — | EP | claimed |
| EP-0125290-A1 | PEPTIDES AFFECTING GONADAL FUNCTION. | SALK INST FOR BIOLOGICAL STUDI (US) | 1984-11-21 | — | — | EP | claimed |
| EP-0122712-A2 | GnRH antagonists | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1984-10-24 | — | — | EP | claimed |
| WO-1984002341-A1 | GnRH AGONISTS | SALK INST FOR BIOLOGICAL STUDI (US) | 1984-06-21 | — | — | WO | claimed |
| WO-1984001771-A1 | PEPTIDES AFFECTING GONADAL FUNCTION | SALK INST FOR BIOLOGICAL STUDI (US) | 1984-05-10 | — | — | WO | claimed |
| EP-0107963-A1 | Indole derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-05-09 | — | — | EP | claimed |
| US-4342671-A | FOR TREATMENT OF ACROMEGALY AND DIABETES, INHIBITS RELEASE OF GROWTH HORMONE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1982-08-03 | — | — | US | claimed |
| EP-0004664-B1 | A PROCESS FOR PREPARING LYSERGOL DERIVATIVES | Corvi Mora, Enrico (IT) | 1982-04-14 | — | — | EP | claimed |
| US-4232157-A | Process for preparing lysergol derivatives | ISTITUTO CHEMIOTERAPICO DI LODI SPA, A CORP OF ITALY (IT) | 1980-11-04 | — | — | US | claimed |
| EP-0004664-A1 | A process for preparing lysergol derivatives | Corvi Mora, Enrico (IT) | 1979-10-17 | — | — | EP | claimed |